Funded Tech Companies

Cayuga Biotech

Wondering who invested in Cayuga Biotech? Purchase Capital, SOSV and private investors joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Cayuga Biotech, a clinical-stage biopharmaceutical company, is developing novel therapies to address life-threatening hemorrhage by harnessing the body's innate ability to stop bleeding. Cayuga's pipeline includes clinical-stage CAY001 (polyP-SNP complex), in development for acute major hemorrhage, CAY002, a discovery-stage program for inherited bleeding disorders and a portfolio of early-stage programs across the healing continuum.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/11/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andrea Ashford-Hicks

        

Company Investors

• Purchase Capital
• SOSV
• NuFund Venture Group
• Defense Health Agency
• Walnut Venture Associates
• Wharton Alumni Angels (James Carroll)
• Sidecar Angels
• TBD Angels
• Mass Medical Angels
• New York Ventures
• Gopher Angels

Browse more funded tech companies:

Cayosoft | Cazena

Share this article

About Our Venture Capital Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary